Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro.

Saved in:

Bibliographic Details
Title:	Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro.
Authors:	Wang, Rui-Rui¹, Yang, Qing-Hua², Luo, Rong-Hua¹, Peng, You-Mei², Dai, Shao-Xing³, Zhang, Xing-Jie^1,4, Chen, Huan^1,4, Cui, Xue-Qing^1,5, Liu, Ya-Juan^1,4, Huang, Jing-Fei³, Chang, Jun-Biao² changjunbiao@zzu.edu.cn, Zheng, Yong-Tang¹ zhengyt@mail.kiz.ac.cn
Source:	PLoS ONE. Aug2014, Vol. 9 Issue 8, p1-11. 11p.
Database:	Academic Search Ultimate

Description
ISSN:	19326203
DOI:	10.1371/journal.pone.0105617